Protein S Deficiency Differential Diagnoses

Updated: Sep 20, 2018
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Perumal Thiagarajan, MD  more...
  • Print
DDx

Diagnostic Considerations

Given the rarity of inherited protein S deficiency, testing for this disorder should not be considered in unselected patients with venous thromboembolism (VTE). However, screening for inherited thrombophilia is appropriate in cases of the following [21] :

  • VTE without obvious cause in patients younger than 45 to 50 years
  • VTE in patients with a family history of thrombosis
  • Recurrent VTE
  • Thrombosis at an unusual location
  • VTE during pregnancy, use of oral contraceptives, or hormone replacement therapy

Patients who develop  VTE in the absence of acquired risk factors may have protein S deficiency or some other congenital thrombophilia, or may have more than one congenital risk factor for VTE. In a retrospective analysis of prospectively gathered data on 58 outpatients with VTE (approximate mean age 39 years) without major acquired risk factors, 45 had at least one hereditary risk factor for VTE. Diagnoses in these patients were as follows [26] :

  • Protein S deficiency - 17 patients

  • Protein C deficiency - 18 patients

  • Factor V Leiden mutation - 30 patients (25 heterozygous and five 5 homozygous)

  • Prothrombin gene mutation - 16 patients

  • Methylenetetrahydrofolate reductase C677T mutation - 24 patients (19 heterozygous, 5 homozygous)

  • Antithrombin III deficiency - 14 patients

  • Hyperhomocysteinemia - 13 patients

Of the 17 patients with protein S deficiency, 13 also had protein C deficiency, hyperhomocystinemia, antithrombin III deficiency, or some combination of those conditions.

These authors concluded that thrombophilia testing should be performed in younger VTE patients without known acquired risk factors. Testing for protein C, protein S, and prothrombin gene mutations should be followed by additional molecular assessment in patients with suspicious findings. [26]

Similarly, in a cohort of 367 unselected pediatric patients with VTE, Klostermeier et al found that 30 children (8.2%) from 27 families had protein S deficiency. After adjustment for family status, the prevalence of protein S deficiency was 7.4 %. Mean age at first onset of VTE was 14.5 years.

Of the 30 children with protein S deficiency, 18 (60%) had a concomitant risk factor for VTE. The factor V mutation at rs6025 and the homozygous factor II susceptibility variant at rs1799963 were observed along with protein S deficiency in one patient each, and the Heerlen polymorphism was found in five children with milder protein S deficiency. These researchers concluded that thrombophilia testing and consideration of appropriate interventions are warranted in this high-risk group of patients. [27]

Differential Diagnoses